The UK’s Medicines and Healthcare products Regulatory Agency has approved Eli Lilly's new treatment for early-stage Alzheimer’s disease, donanemab, marketed under the brand name Kisunla.
Read More
HCG announced the launch of outpatient (OPD) consultations in Goa, expanding access to specialised cancer treatments for local patients. In collaboration with local hospitals.
Read More_20241023194057_original_image_15.webp)
The study surveyed 400 doctors across various specialties and experience levels, highlighting a significant shift in the approach to medical education in response to rapid advancements in healthcare
Read More
Fortis Hospital Bannerghatta Road successfully treated a 16-year-old boy from Africa suffering from severe aplastic anaemia, a life-threatening condition where the bone marrow fails to produce sufficient blood cells.
Read More
Niva Bupa Health Insurance, backed by private equity firm True North (formerly Max Bupa), has received final approval from the Securities and Exchange Board of India (SEBI) to raise Rs 3,000 crore through an initial public offering (IPO).
Read More_20241022173808_original_image_6.webp)
Focus on carbon neutrality, renewable energy, and employee development in line with sustainability targets
Read More
The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) has reached ₹1000 crore in sales by October 2024, significantly earlier than last year, when this target was met in December. This milestone underscores the increasing public trust in affordable, high-quality medicines provided through the initiative.
Read More_20241022163422_original_image_22.webp)
India's Midwifery Revolution may transform maternal care by ensuring safe, respectful, and high-quality birthing experiences for women nationwide.
Read More
A patient-centric HMIS is designed with the active involvement of patients, healthcare providers, and administrators in mind. It moves away from traditional systems, which often emphasise data management and compliance, creating solutions that feel disconnected from the user. By prioritizing user experience, healthcare organisations can develop systems that are functional, intuitive, and accessible, ultimately improving the quality of care.
Read More
Niva Bupa Health Insurance Company and Paras Healthcare have received regulatory approval from the Securities and Exchange Board of India (SEBI) to move forward with their Initial Public Offerings (IPOs). The approvals, granted on October 18, allow both companies to raise capital through a mix of fresh equity and Offer for Sale (OFS) components.
Read More
